Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Pfizer to acquire Neksium brand from AstraZeneca for Rs 75 cr

      Pfizer to acquire Neksium brand from AstraZeneca for Rs 75 cr

      Ruby Khatun Khatun1 Jun 2017 12:37 PM IST
      New Delhi: Drug firm Pfizer Ltd said it has entered into a pact with AstraZeneca AB, Sweden to acquire the 'Neksium' brand in India for Rs 75 crore to...
      Sun Pharma recalls 13K bottles of chewable Cetirizine in US

      Sun Pharma recalls 13K bottles of chewable Cetirizine in US

      Ruby Khatun Khatun1 Jun 2017 12:28 PM IST
      New Delhi: The US arm of domestic drug major Sun Pharma is recalling over 13,000 bottles of antihistamine, Children's Cetirizine Hydrochloride...
      EC Approves TRUMENBA-Pfizer’s Meningococcal Vaccine

      EC Approves TRUMENBA-Pfizer’s Meningococcal Vaccine

      Ruby Khatun Khatun1 Jun 2017 12:27 PM IST
      NEW YORK: Pfizer Inc. announced that the European Commission (EC) has approved TRUMENBA® (Meningococcal Group B Vaccine) for the prevention of...
      Swiss biotech NLS Pharmas ADHD drug succeeds in mid-stage study

      Swiss biotech NLS Pharmas ADHD drug succeeds in mid-stage study

      Ruby Khatun Khatun1 Jun 2017 12:23 PM IST
      Swiss biotech NLS Pharma AG said on Wednesday mid-stage trial data showed that its drug to treat attention deficit hyperactivity disorder (ADHD)...
      Zydus Cadila gets USFDA nod for generic epilepsy drug

      Zydus Cadila gets USFDA nod for generic epilepsy drug

      Ruby Khatun Khatun1 Jun 2017 12:00 PM IST
      New Delhi: Drug firm Zydus Cadila has received the US health regulators nod to market Felbamate tablets, used to treat seizures in people with...
      Gilead and GSK go head to head with similar HIV drug data

      Gilead and GSK go head to head with similar HIV drug data

      Ruby Khatun Khatun1 Jun 2017 9:42 AM IST
      Gilead Sciences Inc and GlaxoSmithKline Plc (GSK) will go head-to-head with rival versions of an improved class of HIV medicines, after clinical...
      Unichem Laboratories Q4 net profit up 13% at Rs 31.46 cr

      Unichem Laboratories Q4 net profit up 13% at Rs 31.46 cr

      Ruby Khatun Khatun1 Jun 2017 9:10 AM IST
      New Delhi: Drug firm Unichem Laboratories reported a 13.61 per cent increase in standalone net profit at Rs 31.46 crore for the fourth quarter ended...
      Natco Pharma Q4 surges nearly 3-fold at Rs 176.7 cr

      Natco Pharma Q4 surges nearly 3-fold at Rs 176.7 cr

      Ruby Khatun Khatun1 Jun 2017 9:01 AM IST
      Hyderabad: NATCO Pharma Limited has recorded consolidated total revenue of INR 2078.9 Crore for the year ended on 31 st March, 2017, as against INR...
      Mylan may have overcharged US for EpiPen by 1.27 billion dollar: HHS

      Mylan may have overcharged US for EpiPen by 1.27 billion dollar: HHS

      Ruby Khatun Khatun1 Jun 2017 9:00 AM IST
      NEW YORK: The U.S. government may have overpaid drugmaker Mylan N.V. by as much as $1.27 billion between 2006 and 2016 for its EpiPen emergency...
      VLCC acquires nutraceutical maker Wellscience

      VLCC acquires nutraceutical maker Wellscience

      Ruby Khatun Khatun31 May 2017 11:41 AM IST
      New Delhi: Beauty and wellness firm VLCC said it has acquired nutraceutical products maker Wellscience that would enable entry into the new...
      Strides Shasun gets 3 observations from USFDA for Bangalore plant

      Strides Shasun gets 3 observations from USFDA for Bangalore plant

      Ruby Khatun Khatun31 May 2017 11:38 AM IST
      New Delhi: Drug firm Strides Shasun said the US health regulator has issued 3 observations after inspecting its formulations facility in...
      Spain arrests 14 on suspicion of making, selling performance-enhancing drugs

      Spain arrests 14 on suspicion of making, selling performance-enhancing drugs

      Ruby Khatun Khatun31 May 2017 11:38 AM IST
      Spain: Spanish police raided 25 homes, warehouses and gymnasiums and arrested 14 people accused of belonging to a network manufacturing and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok